Lisa Walz is a Senior Clinical Research Scientist at Genmab, specializing in phase 2/3 hematology-oncology therapies. With over five years of experience in clinical development, they have demonstrated expertise in vaccine development and infectious diseases during their time at MorphoSys and CureVac. They have a strong background in leading clinical trial documentation and collaborating across international teams to ensure successful project outcomes. Lisa holds a PhD in Virology from Johannes Gutenberg-Universität Mainz and a Bachelor of Science in Biology from Julius-Maximilians-Universität Würzburg.
This person is not in the org chart
This person is not in any teams
This person is not in any offices